Latest News

 Filter by Provider

Navitas Semiconductor (NASDAQ: NVTS) has experienced an extraordinary market surge in late 2024 and throughout 2025, driven by its pivotal role in powering the next generation of artificial intelligence. The company's innovative Gallium Nitride (GaN) and Silicon Carbide (SiC) power semiconductors are now at the heart of Nvidia's (NASDAQ: NVDA) ambitious "AI factory" computing platforms, [...]

The S&P climbed 31 handles today. Meanwhile, volatility futures are climbing right alongside it.

Airline company United Airlines Holdings (NASDAQ:UAL) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.6% year on year to $15.23 billion. Its non-GAAP profit of $2.78 per share was 4% above analysts’ consensus estimates.

Utilizing the payout ratio reveals these 3 dividend stocks are likely to cut their dividends in the future.

Some investors were concerned that the company is spending a considerable chunk of cash for a collection of intangible assets.

Technical analysis on the stock chart for CRWD.

Regional banking company Banner Corporation (NASDAQ:BANR) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $170.7 million. Its GAAP profit of $1.54 per share was 10% above analysts’ consensus estimates.

First Industrial Realty Trust (FR) reported mixed Q3 2025 results, with FFO per share beating estimates at $0.76, while revenue of $181.43M missed projections.

Martin Midstream Partners (MMLP) reported a major Q3 2025 earnings and revenue miss, withdrew its full-year guidance, and saw its stock drop sharply.

SL Green's Q3 2025 results show a strong FFO beat but a revenue miss, reflecting a mixed outlook for the Manhattan office REIT amid market challenges.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Bank of America stock is already up 19% year-to-date.

A Marijuana Moment report cites findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions.

Rigetti CEO exercised options for 1M shares, then sold them, leaving him with zero. This unusual move raises questions about...

Convincing year-over-year gains in core fundamentals weren't satisfying enough for Mr. Market.

The South African telematics leader reported strong growth, but a compression in margins. However, the sell-off could be a buying opportunity.

Bitfarms shares are falling in Wednesday's after-hours session after the company announced a convertible senior notes offering.

AMD stock was flying today. Here's why.

Over 27,000 call options expiring in 9 days on Oct. 24 have traded at the $55.00 strike price, i.e., out-of-the-money (OTM).

Bill Ackman bet on two Magnificent 7 stocks in the second quarter. One is up since then and one is down.

Triumph Financial Q3 2025 results: EPS of $0.19 beats estimates, but revenue of $109.28M misses forecasts. A mixed earnings report.

Banner Corp (BANR) beat Q3 earnings estimates with EPS of $1.54 and revenue of $170.7M. The company also raised its dividend, signaling strong financial health.

J.B. Hunt Q3 2025 earnings beat estimates with EPS of $1.76. Strong profit growth driven by cost control, despite a slight revenue miss.

Rexford Industrial Q3 2025 results: EPS of $0.60 beats estimates, but revenue of $253.24M slightly misses forecasts.

The data center company's stock is moving higher. Here's why.

As Japan prepares for a new prime minister, investors are eyeing a potential revival in growth and undervalued equities.

J.B. Hunt stock rallies after-hours Wednesday after the company beat Q3 expectations on the top and bottom lines.

Almost every day, a new gold price forecast hits the wire — but what dropped Thursday from Ed Yardeni could make even the bulls blink.

The volatility in LAC stock might not be a harbinger of doom; instead, it could very well provide the green light for the bulls.

Financial services company Triumph Financial (NASDAQ:TFIN) missed Wall Street’s revenue expectations in Q3 CY2025 as sales rose 3% year on year to $109.3 million. Its GAAP profit of $0.04 per share decreased from $0.19 in the same quarter last year.

Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments

Technical analysis on the NVDA chart.

Gold may outshine AI in 2025 due to rising debt risks, investor Ray Dalio says. It's up over 50% so far this year.